Role of a NK receptor, KLRE-1, in bone marrow allograft rejection: Analysis with KLRE-1-deficient mice

Blood

Volumn 104, Issue 3, 2004, Pages 781-783

  Shimizu, Eiko ^b   Koike, Junzo ^b   Wakao, Hiroshi ^b   Seino, Ken Iohiro ^b   Koseki, Haruhiko ^b   Kakiuchi, Terutaka ^b   Nakayama, Toshinori ^b   Taniguchi, Masaru ^a  

^a RIKEN   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

KILLER CELL LECTIN LIKE RECEPTOR 1; LYMPHOCYTE MEMBRANE RECEPTOR; NATURAL KILLER CELL RECEPTOR; UNCLASSIFIED DRUG;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLONY FORMATION; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; GRAFT REJECTION; KNOCKOUT MOUSE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING; WILD TYPE;

EID: 3242806081     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-10-3468     Document Type: Article

References (15)

1. Murphy WJ, Kumar V, Bennett M. Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID): evidence that natural killer cells can mediate the specificity of marrow graft rejection. J Exp Med. 1987;165:1212-1217.
2. Trinchleri G. Biology of natural killer cells. Adv Immunol. 1989;47:187-376.
3. Lanier LL. NK cell receptors. Annu Rev Immunol. 1998;16:359-393.
4. Yokoyama WM. Natural killer cell receptors. Curr Opin Immunol. 1998;10:298-305.
5. Toyama-Sorimachi N, Taguchi Y, Yagita H, et al. Mouse CD94 participates in Qa-1-mediated self recognition by NK cells and delivers inhibitory signals independent of Ly-49. J Immunol. 2001;166:3771-3779.
6. Raziuddin A, Longo DL, Mason L, Ortaldo JR, Bennett M, Murphy WJ. Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets. J Immunol. 1998;160:87-94.
7. Makrigiannis AP, Gosselin P, Mason LH, et al. Cloning and characterization of a novel activating Ly49 closely related to Ly49A. J Immunol. 1999;163:4931-4938.
8. Makrigiannis AP, Etzler J, Winkler-Pickett R, Mason A, Ortaldo JR, Anderson SK. Identification of the Ly49L protein: evidence for activating counterparts to inhibitory Ly49 proteins. J Leukoc Biol. 2000;68:765-771.
9. Daniels KA, Devora G, Lai WC, O'Donnell CL, Bennett M, Welsh RM. Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J Exp Med. 2001;194:29-44.
10. Van Beneden K, Stevenaert F, De Creus A, et al. Expression of Ly49E and CD94/NKG2 on fetal and adult NK cells. J Immunol. 2001;166:4302-4311.
11. Wilhelm BT, Mager DL. Identification of a new murine lectin-like gene in close proximity to CD94. Immunogenetics. 2003;55:53-56.
12. Westgaard IH, Dissen E, Torgersen KM, et al. The lectin-like receptor KLRE1 inhibits natural killer cell cytotoxicity. J Exp Med. 2003;197:1551-1561.
13. Koike J, Wakao H, Tshizuka Y, et al. Bone marrow allograft rejection mediated by a novel murine NK receptor, NKG21. J Exp Med. 2004;199:137-144.
14. Akasaka T, Kanno M, Balling R, Mieza MA, Taniguchi M, Koseki H. A role for mel-18, a Polycomb group-related vertebrate gene, during theanteroposterior specification of the axial skeleton. Development. 1996;122:1513-1522.
15. Kaneko Y, Harada M, Kawano T, et al. Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J Exp Med. 2000;191:105-114.